Idera Pharma down 11% premarket on updated mid-stage tilsotolimod data [Seeking Alpha]
Idera Pharmaceuticals, Inc. (IDRA)
Last idera pharmaceuticals, inc. earnings: 11/6 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.iderapharma.com/investor-overview
Company Research
Source: Seeking Alpha
Idera Pharmaceuticals (NASDAQ: IDRA ) is down premarket on light volume following its release of updated results from the Phase 2 ILLUMINATE-204 study evaluating tilsotolimod plus Bristol-Myers Squibb's (NYSE: BMY ) Yervoy (ipilimumab) in advanced melanoma patients who failed to respond to PD-1 inhibitor therapy [Merck's (NYSE: MRK ) Keytruda (pembrolizumab)]. 34 patients were evaluable for efficacy and 37 for safety. The overall response rate (ORR) was 32% (n=11/34), including two complete responders. Using RECIST v1.1 criteria, the ORR was 29%. The disease control rate (responders + stable cancer) was 76% (n=26/34). No new safety signals were observed. In October, the company reported an ORR of 39% (n=8/21 which is actually 38%) which was consistent with the results reported in June. Previously: Idera presents new data on tilsotolimod; investors unmoved, shares down 8% (Oct. 19) See all stocks on the move » Now read: Axovant in-licenses two new g
Show less
Read more
Impact Snapshot
Event Time:
IDRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IDRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IDRA alerts
High impacting Idera Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics